Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract-Reference-Cited by-同舟云学术

Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract

Published:2018-05-24 Issue:2 Volume:54 Page:212-217
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ganetsky Alex,Frey Noelle V.,Hexner Elizabeth O.,Loren Alison W.,Gill Saar I.,Luger Selina M.,Mangan James K.,Martin Mary Ellen,Babushok Daria V.,Drobyski William R.,Smith Jacqueline,Timlin Colleen,Freyer Craig W.,Stadtmauer Edward A.,Porter David L.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0236-z.pdf

Reference20 articles.

1. D’Souza A, Fretham C Current Uses and Outcomes of Hematopoietic Cell Transplantation (HCT): CIBMTR Summary Slides, 2017. Available at: http://www.cibmtr.org

2. Jagasia M, Arora M, Flowers ME, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296–307.

3. Pavletic SZ, Fowler DH. Are we making progress in GVHD prophylaxis and treatment? Hematol Am Soc Hematol Educ Program. 2012;2012:251–64.

4. Xhaard A, Rocha V, Bueno B, de Latour RP, Lenglet J, Petropoulou A, et al. Steroid-refractory acute GVHD: Lack of long-term improved survival using new generation anticytokine treatment. Biol Blood Marrow Transplant. 2012;18:406–13.

5. Castilla-Llorente C, Martin PJ, McDonald GB, Storer BE, Appelbaum FR, Deeg HJ, et al. Prognostic factors and outcomes of severe gastrointestinal graft-vs.-host disease after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2014;49:966–71.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New investigational drugs for steroid-refractory acute graft-versus-host disease: a review of the literature;Expert Opinion on Investigational Drugs;2024-07-09

2. Treatment of steroid-refractory graft versus host disease in children;Frontiers in Transplantation;2023-09-15

3. Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis;Transplantation and Cellular Therapy;2023-08

4. Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials;Frontiers in Immunology;2023-06-20

5. Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction;Pharmacological Reviews;2023-06-09